Severity
Moderate
FDA Drug recall · Reported August 26, 2020
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Calvin Scott & Company, Inc. recalled Topiramate 25mg Tabs White/round tablets, 10-count bags, Distributed by: Calvin Scott & C… - a moderate-severity action.
Topiramate 25mg Tabs White/round tablets, 10-count bags, Distributed by: Calvin Scott & C… was recalled by Calvin Scott & Company, Inc. in August 26, 2020. Reason: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.. Check the official notice for the remedy. Verify recall #D-1520-2020 with the FDA Drug before acting.
The recall
Calvin Scott & Company, Inc. issued this moderate-severity FDA Drug recall-CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches..
Sourced from official FDA Drug enforcement records. Verify recall #D-1520-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1520-2020) was formally reported on August 26, 2020, with the manufacturer initiating the action on July 27, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. Calvin Scott & Company, Inc. is listed as the recalling firm, operating out of Albuquerque, NM. Federal records list the affected scope as N/A.
The documented reason for this recall is: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches. Distribution data in the federal record shows the product reached: Nationwide within the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
N/A
Related Recalls
6
5 from same agency
Topiramate 25mg Tabs White/round tablets, 10-count bags, Distributed by: Calvin Scott & Co., Inc. Alb., MN 87123, Mfg: Sun Pharm., Inc. Cranbury, NJ 08512, NDC 47335-0707-13
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1520-2020 |
| Date reported | August 26, 2020 |
| Date initiated | July 27, 2020 |
| Recalling firm | Calvin Scott & Company, Inc. |
| Firm location | Albuquerque, NM |
| Affected scope | N/A |
| Distribution | Nationwide within the United States |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 26, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.